Mutation analysis of 2009 pandemic influenza a(H1N1) viruses collected in Japan during the peak phase of the pandemic

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Morlighem, Jean Étienne ^a   Aoki, Shintaro ^a   Kishima, Mami ^a   Hanami, Mitsue ^a   Ogawa, Chihiro ^a   Jalloh, Amadu ^a   Takahashi, Yukari ^a   Kawai, Yuki ^a   Saga, Satomi ^a   Hayashi, Eiji ^b   Ban, Toshiaki ^c   Izumi, Shinyu ^d   Wada, Akira ^e   Mano, Masayuki ^e   Fukunaga, Megumu ^f   Kijima, Yoshiyuki ^g   Shiomi, Shoji ^g   Inoue, Kaoru ^g   Hata, Takeshi ^g   Koretsune, Yukihiro ^e   Kudo, Koichiro ^d   Himeno, Yuji ^c   Hirai, Aizan ^b   Takahashi, Kazuo ^h   Sakai Tagawa, Yuko ⁱ   Iwatsuki Horimoto, Kiyoko ⁱ   Kawaoka, Yoshihiro ⁱ   Hayashizaki, Yoshihide ^a   Ishikawa, Toshihisa ^a   more..

^a RIKEN YOKOHAMA INSTITUTE   (Japan)

^b Chiba Prefectural Togane Hospital   (Japan)

^c Isumi Medical Center   (Japan)

^d NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^e OSAKA NATIONAL HOSPITAL   (Japan)

^f TOYONAKA MUNICIPAL HOSPITAL   (Japan)

^g OSAKA CITY GENERAL HOSPITAL   (Japan)

^h OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

ⁱ UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; OSELTAMIVIR; SIALIDASE; STEROID; VIRUS RNA; ANTIVIRUS AGENT; VIRUS HEMAGGLUTININ; VIRUS PROTEIN;

2009 H1N1 INFLUENZA; ANTIVIRAL RESISTANCE; ARTICLE; CHILD; CONTROLLED STUDY; DRUG PULSE THERAPY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; GENE CLUSTER; GEOGRAPHIC DISTRIBUTION; HA GENE; HUMAN; INFLUENZA VIRUS A H1N1; JAPAN; MAJOR CLINICAL STUDY; NA GENE; PHYLOGENY; PRESCHOOL CHILD; SEQUENCE ANALYSIS; SPANISH INFLUENZA; VIRUS GENE; VIRUS MUTATION; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; BAYES THEOREM; CHEMICAL STRUCTURE; CHEMISTRY; CLASSIFICATION; CLUSTER ANALYSIS; DRUG EFFECT; GENETICS; INFLUENZA; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; PANDEMIC; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; SEASON; VIROLOGY;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIVIRAL AGENTS; BAYES THEOREM; CLUSTER ANALYSIS; DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE, VIRAL; HEMAGGLUTININS, VIRAL; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; JAPAN; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; NEURAMINIDASE; OSELTAMIVIR; PANDEMICS; PHYLOGENY; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; SEASONS; VIRAL PROTEINS;

EID: 79955743374     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018956     Document Type: Article

References (55)

1. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team (2009) Emergence of a novel swine-origin influenza A(H1N1) virus in humans. N Engl J Med 360: 2605-2615.
2. Schnitzler SU, Schnitzler P, (2009) An update on swine-origin influenza virus A/H1N1: a review. Virus Genes 39: 279-292.
3. Centers for Disease Control and Prevention (CDC) (2009) Update: novel influenza A (H1N1) virus infections- worldwide, May 6, 2009. MMWR Morb Mortal Wkly Rep 58: 453-458.
4. World Health Organization (WHO) (2010) Pandemic (H1N1) 2009- update 97. Available:http://www.who.int/csr/don/2010_04_23a/en/index.html. Accessed 2010 April 23.
5. World Health Organization (WHO) (2010) H1N1 in post-pandemic period. Available:www.who.int/mediacentre/news/statements/2010/h1n1_vpc_20100810/en/index.html. Accessed 2010 August 10.
6. World Health Organization (WHO) (2010) Influenza- update 115. Available:www.who.int/csr/don/2010_08_27/en/index.html. Accessed 2010 August 27.
7. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, et al. (2009) Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325: 197-201.
8. Neumann G, Noda T, Kawaoka Y, (2009) Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459: 931-939.
9. Centers for Disease Control and Prevention (CDC) (2010) Update: influenza activity- United States, August 30, 2009-March 27, 2010, and composition of the 2010-11 influenza vaccine. MMWR Morb Mortal Wkly Rep 59: 423-430.
10. Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, et al. (2009) In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460: 1021-1025.
11. Pan C, Cheung B, Tan S, Li C, Li L, et al. (2010) Genomic signature and mutation trend analysis of pandemic (H1N1) 2009 influenza A virus. PLoS One 5: e9549.
12. Xu R, Ekiert DC, Krause JC, Hai R, Crowe JE Jr, et al. (2010) Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus. Science 328: 357-360.
13. Nelson M, Spiro D, Wentworth D, Beck E, Fan J, et al. (2009) The early diversification of influenza A/H1N1pdm. PLoS Curr 1: RRN1126.
14. Fereidouni SR, Beer M, Vahlenkamp T, Starick E, (2009) Differentiation of two distinct clusters among currently circulating influenza A(H1N1) viruses, March-September 2009. Euro Surveill 14 pii: 19409.
15. Smith GJ, Vijaykrishna D, Bahl J, Lycett SJ, Worobey M, et al. (2009) Origin and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 459: 1122-1125.
16. Infectious Disease Surveillance Center (IDSC) (2009) The novel influenza (in Japanese). Available:http://idsc.nih.go.jp/idwr/douko/2009d/18-19douko.html. Accessed 2010 November 03.
17. Shiino T, Okabe N, Yasui Y, Sunagawa T, Ujike M, et al. (2010) Molecular evolutionary analysis of the influenza A(H1N1)pdm, May-September, 2009: temporal and spatial spreading profile of the viruses in Japan. PLoS ONE 5: e11057.
18. NCBI Influenza Virus Resource. Available:www.ncbi.nlm.nih.gov/genomes/FLU/FLU.html. Accessed 2011 February 07.
19. Kiso M, Mitamura K, Sakai-Tagawa Y, Shiraishi K, Kawakami C, et al. (2004) Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet 364: 759-765.
20. Le QM, Kiso M, Someya K, Sakai YT, Nguyen TH, et al. (2005) Avian flu: isolation of drug-resistant H5N1 virus. Nature 437: 1108.
21. Collins PJ, Haire LF, Lin YP, Liu J, Russell RJ, et al. (2008) Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants. Nature 453: 1258-1261.
22. Sheerar MG, Easterday BC, Hinshaw VS, (1989) Antigenic conservation of H1N1 swine influenza viruses. J Gen Virol 70: 3297-3303.
23. Luoh SM, McGregor MW, Hinshaw VS, (1992) Hemagglutinin mutations related to antigenic variation in H1 swine influenza viruses. J Virol 66: 1066-1073.
24. Taubenberger JK, Reid AH, Krafft AE, Bijwaard KE, Fanning TG, (1997) Initial genetic characterization of the 1918 "Spanish" influenza virus. Science 275: 1793-1796.
25. Reid AH, Fanning TG, Hultin JV, Taubenberger JK, (1999) Origin and evolution of the 1918 "Spanish" influenza virus hemagglutinin gene. Proc Natl Acad Sci U S A 96: 1651-1656.
26. Reid AH, Janczewski TA, Lourens RM, Elliot AJ, Daniels RS, et al. (2003) 1918 influenza pandemic caused by highly conserved viruses with two receptor-binding variants. Emerg Infect Dis 9: 1249-1253.
27. Kilander A, Rykkvin R, Dudman SG, Hungnes O, (2010) Observed association between the HA1 mutation D222G in the 2009 pandemic influenza A(H1N1) virus and severe clinical outcome, Norway 2009-2010. Euro Surveill 15: 19498.
28. Skehel JJ, Stevens DJ, Daniels RS, Douglas AR, Knossow M, et al. (1984) A carbohydrate side-chain on hemagglutinins of Hong Kong influenza-viruses inhibits recognition by a monoclonal-antibody. Proc Natl Acad Sci U S A 81: 1779-1783.
29. Deshpande KL, Fried VA, Ando M, Webster RG, (1987) Glycosylation affects cleavage of an H5N2 influenza-virus hemagglutinin and regulates virulence. Proc Natl Acad Sci U S A 84: 36-40.
30. Gunther I, Glatthaar B, Doller G, Garten W, (1993) A H1-hemagglutinin of a human influenza A-virus with a carbohydrate-modulated receptor-binding site and an unusual cleavage site. Virus Res 27: 147-160.
31. Gubareva LV, Kaiser L, Hayden FG, (2000) Influenza virus neuraminidase inhibitors. Lancet 355: 827-835.
32. Zambon M, Hayden FG, (2001) Position statement: global neuraminidase inhibitor susceptibility network. Antiviral Res 49: 147-156.
33. Centers for Disease Control and Prevention (CDC) (2009) Oseltamivir-resistant novel influenza A(H1N1) virus infection in two immunosuppressed patients - Seattle,Washington, 2009. MMWR Morb Mortal Wkly Rep 58: 893-896.
34. Leung TW, Tai AL, Cheng PK, Kong MS, Lim W, (2009) Detection of an oseltamivir-resistant pandemic influenza A/H1N1 virus in Hong Kong. J Clin Virol 46: 298-299.
35. Le QM, Wertheim HF, Tran HD, van Doorn HR, Nguyen TH, et al. (2010) A community cluster of oseltamivir-resistant cases. N Eng J Med 362: 86-87.
36. Kiso M, Shinya K, Shimojima M, Takano R, Takahashi K, et al. (2010) Characterization of oseltamivir-resistant 2009 H1N1 pandemic influenza A viruses. PLoS Pathogens 6: e1001079.
37. World Health Organization (WHO) (2008) Influenza A(H1N1) virus resistance to oseltamivir- Last quarter 2007 to 17 April 2008. Available:www.who.int/csr/disease/influenza/H1N1ResistanceWeb20080417.pdf. Accessed 2008 April 17.
38. Matsuzaki Y, Mizuta K, Aoki Y, Suto A, Abiko C, et al. (2010) A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir. Virol J 7: 53.
39. Baranovich T, Saito R, Suzuki Y, Zaraket H, Dapat C, et al. (2010) Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season. J Clin Virol 47: 23-28.
40. Yang H, Carney P, Stevens J, (2010) Structure and Receptor binding properties of a pandemic H1N1 virus hemagglutinin. PLoS Curr Influenza 2: RRN1152.
41. Das K, Aramini JM, Ma LC, Krug RM, Arnold E, (2010) Structures of influenza A proteins and insights into antiviral drug targets. Nat Struct Mol Biol 17: 530-538.
42. Castrucci MR, Kawaoka Y, (1993) Biologic importance of neuraminidase stalk length in influenza A virus. J Virol 67: 759-764.
43. Zhou H, Yu Z, Hu Y, Tu J, Zou W, et al. (2009) The special neuraminidase stalk-motif responsible for increased virulence and pathogenesis of H5N1 influenza A virus. PLoS One 4: e6277.
44. Munier S, Larcher T, Cormier-Aline F, Soubieux D, Su B, et al. (2010) A genetically engineered waterfowl influenza virus with a deletion in the stalk of the neuraminidase has increased virulence for chickens. J Virol 84: 940-952.
45. Zhou B, Donnelly ME, Scholes DT, St George K, Hatta M, et al. (2009) Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and swine origin human influenza A viruses. J Virol 83: 10309-10313.
46. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, et al. (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23: 2947-2948.
47. Tamura K, Dudley J, Nei M, Kumar S, (2007) MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24: 1596-1599.
48. Posada D, (2008) jModelTest: phylogenetic model averaging. Mol Biol Evol 25: 1253-1256.
49. Guindon S, Gascuel O, (2003) A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol 52: 696-704.
50. Drummond AJ, Rambaut A, (2007) BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol 7: 214.
51. Rambaut A, Drummond AJ, (2007) Tracer v1.4, Available:http://beast.bio.ed.ac.uk/Tracer.
52. Available:http://tree.bio.ed.ac.uk/software/figtree/.
53. Sali A, Potterton L, Yuan F, van Vlijmen H, Karplus M, (1995) Evaluation of comparative protein modeling by MODELLER. Proteins 23: 318-326.
54. Guex N, Peitsch MC, (1997) SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling. Electrophoresis 18: 2714-2723.
55. Humphrey W, Dalke A, Schulten K, (1996) VMD: Visual Molecular Dynamics. J Mol Graph 14: 33-38.